Proxy Votes Now

Home › Funds › Davis Opportunity Fund

Davis Opportunity Fund (DGOCX) proxy voting record 2025-2026

Fund family: DAVIS SERIES INC · Filed by DAVIS SERIES INC (CIK 203002) · SEC series S000003442

Share classes and tickers: DGOCX (C000009529), DGOYX (C000009530), RPEAX (C000009527)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 557 with, 42 against, 0 abstentions (not counted as with management); 5 items carried no recommendation. Shareholder proposals: 9 FOR, 37 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other DAVIS SERIES INC funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 71.6% of this fund’s 599 such votes could be given a sector; the other 170 (28.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology1522617.1%
Health Care7733.9%
Finance6146.6%
Consumer Staples5147.8%
Consumer Discretionary4249.5%
Industrials3013.3%
Energy1600.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3790
Corporate Governance6914
Audit-related470
Say-on-Pay310
Compensation263
Capital Structure230
Other Social Issues1111
Environment or Climate88
Extraordinary Transactions60
Human Rights or Human Capital/workforce44

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Viatris Inc.December 5, 2025$57M150
Viatris Inc.May 15, 2026$55M150
Quest Diagnostics IncorporatedMay 20, 2026$53M141
WESCO International, Inc.May 28, 2026$36M120
Devon Energy CorporationJune 30, 2026$29M130
Solventum CorporationMay 15, 2026$27M60
U.S. BancorpApril 21, 2026$27M140
Markel Group Inc.May 20, 2026$25M162

Notable votes against management

MeetingCompanyProposalFundMgmt
May 20, 2026Quest Diagnostics IncorporatedStockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposalAgainstFor
May 20, 2026Markel Group Inc.Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 8, 2026Capital One Financial CorporationStockholder proposal to require a shareholder vote on golden parachute arrangements. Shareholder proposalAgainstFor
February 5, 2026Tyson Foods, Inc.Shareholder proposal regarding disclosure of voting results based on class of shares. Shareholder proposalForAgainst
February 5, 2026Tyson Foods, Inc.Shareholder proposal regarding report on environmental and human health impacts from waste lagoons. Shareholder proposalAgainstFor
April 22, 2026The Cigna GroupShareholder Proposal - Shareholder Right to Act by Written Consent Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
April 16, 2026Texas Instruments IncorporatedStockholder proposal to permit stockholders to act by written consent. Shareholder proposalAgainstFor
June 3, 2026AppLovin CorporationStockholder proposal regarding disclosure of voting results by class of shares, if properly presented at the meeting. Shareholder proposalForAgainst

Search this fund’s votes by company

606 ballot items at 44 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Davis Opportunity Fund (DGOCX) voted at 44 shareholder meetings of 42 companies, on 606 ballot items in all. Where management made a recommendation, the fund followed it on 93.0% of the items and voted against it 42 times. Its most frequent area of disagreement was corporate governance (14 of its votes against management). It voted on 46 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.